MYMD Insider Trading
Insider Ownership Percentage: 2.12%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
MyMD Pharmaceuticals Insider Trading History Chart
This chart shows the insider buying and selling history at MyMD Pharmaceuticals by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
MyMD Pharmaceuticals Share Price & Price History
Current Price: $0.35
Price Change: ▼ Price Decrease of -0.01 (-2.78%)
As of 03/31/2025 01:00 AM ET
MyMD Pharmaceuticals Insider Trading History
MyMD Pharmaceuticals Institutional Trading History
Data available starting January 2016
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
Read More on MyMD Pharmaceuticals
Volume
150,273 shs
Average Volume
134,123 shs
Market Capitalization
$829,500.00
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.15
Who are the company insiders with the largest holdings of MyMD Pharmaceuticals?